(firstQuint)Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis.

 This was a randomized, double-blind, active- and vehicle-controlled study comparing the effects of ME-609, acyclovir in ME-609 vehicle, and vehicle alone.

 Treatment was subject-initiated within 1 hour of experiencing the first signs or symptoms of a herpes recurrence.

 The subject visited a study clinic as soon as possible after treatment initiation, but no later than midnight of the following day, for evaluation.

.

 Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis@highlight

The purpose of this study is to determine whether ME-609 is more efficient than acyclovir and placebo for the treatment of recurrent herpes labialis.

